Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
Active & Responsive
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
for
Immune Thrombocytopenic Purpura (ITP)
Location: Boston MA, The Bronx NY, New York NY, Philadelphia PA,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06722235
Phase 3, Recruiting
Active & Responsive
Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Boston MA, New York NY, Toms River NJ, Philadelphia PA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 50+
Code: NCT07441642
Phase 2, Recruiting
Active & Responsive
Customized TULSA-PRO Ablation Registry
for
Prostate Cancer, Prostate Adenocarcinoma,
Location: York PA, Jacksonville FL, Dallas TX, San Antonio TX,
Sponsor: Profound Medical Inc.
Sex: Male
Age: 18+
Code: NCT05001477
Recruiting
Active & Responsive
Transcranial Magnetic Stimulation + Language Therapy to Treat Mild Aphasia
for
Aphasia, Stroke, Aphasia Following Cerebral Infarction,
Location: Philadelphia PA
Sponsor: University of Pennsylvania
Sex: All
Age: 40 - 70+
Code: NCT06842745
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
for
Lymphoblastic Leukemia
Location: New York NY, Norfolk VA, Hershey PA, Orlando FL,
Sponsor: Tanja Andrea Gruber
Sex: All
Age: 0 - 1
Code: NCT05848687
Phase 1, Phase 2, Recruiting
Active & Responsive
Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)
for
Cutaneous Squamous Cell Carcinoma,
Location: Pittsburgh PA
Sponsor: Falo, Louis, MD
Sex: All
Age: 18+
Code: NCT05377905
Phase 1, Phase 2, Recruiting
Active & Responsive
Dorothy P. and Richard P. Simmons Center for ILD Research Registry
for
Lung Diseases, Interstitial
Location: Pittsburgh PA
Sponsor: University of Pittsburgh
Sex: All
Age: 18+
Code: NCT00258583
Recruiting
Active & Responsive
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
for
Advanced Melanoma
Location: Boston MA, Lake Success NY, New York NY,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT05549297
Phase 3, Recruiting
Active & Responsive
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
for
Bone Pain, Metastatic Malignant Neoplasm in the Bone,
Location: Boston MA, New York NY, Philadelphia PA, Atlanta GA,
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT03858205
Recruiting
Active & Responsive
High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Mezzion Pharma Co. Ltd
Sex: All
Age: 12 - 18
Code: NCT05918211
Phase 3, Recruiting
Active & Responsive
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: Hartford CT, New York NY, Englewood NJ, Florham Park NJ,
Sponsor: VM Oncology, LLC
Sex: All
Age: 18 - 70+
Code: NCT03556228
Phase 1, Phase 2, Recruiting
Active & Responsive
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
for
Endometrial Cancer
Location: New York NY, Albany NY, Doylestown PA, Brandywine MD,
Sponsor: Faeth Therapeutics
Sex: Female
Age: 18+
Code: NCT06463028
Phase 2, Recruiting
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma